Cefoperazone
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01329 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | sclerosing cholangitis | KG + DL |
| 2 | rheumatoid arthritis | KG + DL |
| 3 | pneumonia | KG + DL |
| 4 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 5 | brachydactyly-syndactyly syndrome | KG + DL |
| 6 | gout | KG + DL |
| 7 | bronchitis | KG + DL |
| 8 | meningococcal infection | KG + DL |
| 9 | infectious otitis media | KG + DL |
| 10 | IgG4-related sclerosing cholangitis | KG + DL |
| 11 | bacterial arthritis | KG + DL |
| 12 | middle ear cholesterol granuloma | KG + DL |
| 13 | cholangitis | KG + DL |
| 14 | appendicitis | KG + DL |
| 15 | otosalpingitis | KG + DL |
| 16 | allergic otitis media | KG + DL |
| 17 | suppurative otitis media | KG + DL |
| 18 | chronic otitis media | KG + DL |
| 19 | middle ear disease | KG + DL |
| 20 | osteoarthritis susceptibility | KG + DL |
| 21 | non-suppurative otitis media | KG + DL |
| 22 | suppurative cholangitis | KG + DL |
| 23 | urinary tract infection (disease) | KG + DL |
| 24 | laryngotracheitis | KG + DL |
| 25 | laryngitis | KG + DL |
| 26 | WHIM syndrome | KG + DL |
| 27 | epiglottitis | KG + DL |
| 28 | Ureaplasma urethritis | KG + DL |
| 29 | gonococcal urethritis | KG + DL |
| 30 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 31 | osteoarthritis | KG + DL |
| 32 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 33 | IgG4-related pachymeningitis | KG + DL |
| 34 | myositis | KG + DL |
| 35 | uterine inflammatory disease | KG + DL |
| 36 | peritonitis | KG + DL |
| 37 | paratenonitis | KG + DL |
| 38 | calcific tendinitis | KG + DL |
| 39 | selective IgG subclass deficiency | KG + DL |
| 40 | xanthogranulomatous pyelonephritis | KG + DL |
| 41 | Ledderhose disease | KG + DL |
| 42 | congestive heart failure | KG + DL |
| 43 | staphylococcus aureus infection | KG + DL |
| 44 | IgG4-related retroperitoneal fibrosis | KG + DL |
| 45 | penile fibromatosis | KG + DL |
| 46 | endocarditis | KG + DL |
| 47 | brachyolmia | KG + DL |
| 48 | selective IgG immunodeficiency | KG + DL |
| 49 | diabetic nephropathy | KG + DL |
| 50 | palmar fibromatosis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.